Market Research

Next Generation Sequencers (NGS) Market (Product: Benchtop Sequencers and Floor Standing Sequencers; Technology: WGS, Whole Exome Sequencing, and Targeted Sequencing & Resequencing) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 20

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 180 Pages Transparency Market Research Pvt. Ltd. January, 2024 TNPR18580299
Best Price Guarantee
Price from $5,795
Length 180 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date January, 2024
SKU TNPR18580299

Next Generation Sequencers (NGS) Market (Product: Benchtop Sequencers and Floor Standing Sequencers; Technology: WGS, Whole Exome Sequencing, and Targeted Sequencing & Resequencing) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


Next Generation Sequencers (NGS) Market – Scope of Report

TMR’s report on the global next generation sequencers (NGS) market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global next generation sequencers (NGS) market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global next generation sequencers (NGS) market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the next generation sequencers (NGS) market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global next generation sequencers (NGS) market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global next generation sequencers (NGS) market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global next generation sequencers (NGS) market.

The report delves into the competitive landscape of the global next generation sequencers (NGS) market. Key players operating in the global next generation sequencers (NGS) market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global next generation sequencers (NGS) market profiled in this report.

Key Questions Answered in Global next generation sequencers (NGS) Market Report
  • What is the sales/revenue generated by next generation sequencers (NGS) across all regions during the forecast period?
  • What are the opportunities in the global next generation sequencers (NGS) market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Next Generation Sequencers (NGS) Market – Research Objectives and Research Approach

The comprehensive report on the global next generation sequencers (NGS) market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global next generation sequencers (NGS) market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global next generation sequencers (NGS) market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Next Generation Sequencers (NGS) Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Regulatory Scenario
5.3. COVID-19 Pandemic Impact on Industry
6. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Benchtop Sequencers
6.3.2. Floor Standing Sequencers
6.4. Market Attractiveness Analysis, by Product
7. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Oncology
7.3.2. Infectious Diseases
7.3.3. Reproductive Health
7.3.4. Metagenomics, Epidemiology, and Drug Development
7.3.5. Consumer Genomics
7.4. Market Attractiveness Analysis, by Application
8. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by Technology
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Technology, 2017–2031
8.3.1. WGS
8.3.2. Whole Exome Sequencing
8.3.3. Targeted Sequencing & Resequencing
8.4. Market Attractiveness Analysis, by Technology
9. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Academic Research
9.3.2. Clinical Research
9.3.3. Hospitals & Clinics
9.3.4. Pharma & Biotech Entities
9.3.5. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region
11. North America Next Generation Sequencers (NGS) Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Benchtop Sequencers
11.2.2. Floor Standing Sequencers
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Oncology
11.3.2. Infectious Diseases
11.3.3. Reproductive Health
11.3.4. Metagenomics, Epidemiology, and Drug Development
11.3.5. Consumer Genomics
11.4. Market Value Forecast, by Technology, 2017–2031
11.4.1. WGS
11.4.2. Whole Exome Sequencing
11.4.3. Targeted Sequencing & Resequencing
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Academic Research
11.5.2. Clinical Research
11.5.3. Hospitals & Clinics
11.5.4. Pharma & Biotech Entities
11.5.5. Others
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Application
11.7.3. By Technology
11.7.4. By End-user
11.7.5. By Country
12. Europe Next Generation Sequencers (NGS) Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Benchtop Sequencers
12.2.2. Floor Standing Sequencers
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Oncology
12.3.2. Infectious Diseases
12.3.3. Reproductive Health
12.3.4. Metagenomics, Epidemiology, and Drug Development
12.3.5. Consumer Genomics
12.4. Market Value Forecast, by Technology, 2017–2031
12.4.1. WGS
12.4.2. Whole Exome Sequencing
12.4.3. Targeted Sequencing & Resequencing
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Academic Research
12.5.2. Clinical Research
12.5.3. Hospitals & Clinics
12.5.4. Pharma & Biotech Entities
12.5.5. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Application
12.7.3. By Technology
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Next Generation Sequencers (NGS) Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Benchtop Sequencers
13.2.2. Floor Standing Sequencers
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Oncology
13.3.2. Infectious Diseases
13.3.3. Reproductive Health
13.3.4. Metagenomics, Epidemiology, and Drug Development
13.3.5. Consumer Genomics
13.4. Market Value Forecast, by Technology, 2017–2031
13.4.1. WGS
13.4.2. Whole Exome Sequencing
13.4.3. Targeted Sequencing & Resequencing
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Academic Research
13.5.2. Clinical Research
13.5.3. Hospitals & Clinics
13.5.4. Pharma & Biotech Entities
13.5.5. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Application
13.7.3. By Technology
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Next Generation Sequencers (NGS) Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Benchtop Sequencers
14.2.2. Floor Standing Sequencers
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Oncology
14.3.2. Infectious Diseases
14.3.3. Reproductive Health
14.3.4. Metagenomics, Epidemiology, and Drug Development
14.3.5. Consumer Genomics
14.4. Market Value Forecast, by Technology, 2017–2031
14.4.1. WGS
14.4.2. Whole Exome Sequencing
14.4.3. Targeted Sequencing & Resequencing
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Academic Research
14.5.2. Clinical Research
14.5.3. Hospitals & Clinics
14.5.4. Pharma & Biotech Entities
14.5.5. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Application
14.7.3. By Technology
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Next Generation Sequencers (NGS) Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product, 2017–2031
15.2.1. Benchtop Sequencers
15.2.2. Floor Standing Sequencers
15.3. Market Value Forecast, by Application, 2017–2031
15.3.1. Oncology
15.3.2. Infectious Diseases
15.3.3. Reproductive Health
15.3.4. Metagenomics, Epidemiology, and Drug Development
15.3.5. Consumer Genomics
15.4. Market Value Forecast, by Technology, 2017–2031
15.4.1. WGS
15.4.2. Whole Exome Sequencing
15.4.3. Targeted Sequencing & Resequencing
15.5. Market Value Forecast, by End-user, 2017–2031
15.5.1. Academic Research
15.5.2. Clinical Research
15.5.3. Hospitals & Clinics
15.5.4. Pharma & Biotech Entities
15.5.5. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product
15.7.2. By Application
15.7.3. By Technology
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Illumina, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Thermo Fisher Scientific, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Pacific Biosciences
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Complete Genomics Incorporated
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Vela Diagnostics
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Oxford Nanopore Technologies plc.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Singular Genomics Systems, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. HTG Molecular Diagnostics, Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Revvity
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings